ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,516Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1006

$1.16M Total Retail Price of All Prescriptions

Rank: 29 out of 1006

689 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 15,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 732 675 1 1
LEVOTHYROXINE SODIUM 639 616 2 2
LISINOPRIL 568 548 3 3
WARFARIN SODIUM 526 509 4 8
AMLODIPINE BESYLATE 515 506 5 4
METOPROLOL TARTRATE 453 444 6 7
FUROSEMIDE 446 431 7 6
OMEPRAZOLE 396 385 8 9
METFORMIN HCL 302 269 9 10
MIRTAZAPINE 296 283 10 26
GABAPENTIN 278 270 11 20
ESCITALOPRAM OXALATE 275 248 12 27
DONEPEZIL HCL 244 244 13 17
ATORVASTATIN CALCIUM 200 194 14 5
METOPROLOL SUCCINATE 199 193 15 12
SYNTHROID 186 169 16 42
CYMBALTA 181 179 17 41
TRAZODONE HCL 178 171 18 21
SERTRALINE HCL 177 173 19 19
CLOPIDOGREL 155 155 20 46
HYDROCODONE-ACETAMINOPHEN 150 144 S3 21 25
CRESTOR 146 128 22 18
CITALOPRAM HBR 145 130 23 24
ALLOPURINOL 144 141 24 31
PANTOPRAZOLE SODIUM 143 125 25 32
NAMENDA 142 135 26 34
MELOXICAM 140 135 27 67
PRAVASTATIN SODIUM 138 121 28 15
ALENDRONATE SODIUM 137 135 29 29
ZOLPIDEM TARTRATE 132 127 30 14
HYDROCHLOROTHIAZIDE 117 103 31 11
DIOVAN 116 114 32 16
ATENOLOL 115 103 33 13
LIDODERM 111 110 34 66
TAMSULOSIN HCL 111 104 34 23
PLAVIX 109 109 36 61
AZITHROMYCIN 108 97 37 39
OXYCODONE-ACETAMINOPHEN 106 94 S2 38 57
NEXIUM 106 100 38 28
PAROXETINE HCL 104 86 40 62
BENICAR 102 102 41 78
PREDNISONE 101 93 42 33
EXELON 100 100 43 99
QUETIAPINE FUMARATE 95 95 44 45
KLOR-CON M20 90 87 45 70
GLIMEPIRIDE 89 81 46 50
LOSARTAN POTASSIUM 88 82 47 22
OXYBUTYNIN CHLORIDE ER 88 88 47 92
FENTANYL 84 84 S2 49 74
BYSTOLIC 83 74 50 84
POTASSIUM CHLORIDE 83 83 50 30
RISPERIDONE 79 79 52 40
IPRATROPIUM-ALBUTEROL 78 74 53 73
JANUVIA 78 76 53 49
LEXAPRO 76 71 55 103
ADVAIR DISKUS 75 72 56 37
CIPROFLOXACIN HCL 72 58 57 75
CARVEDILOL 70 67 58 36
NYSTOP 68 62 59 194
NOVOLOG 68 67 59 94
AMLODIPINE BESYLATE-BENAZEPRIL 67 67 61 77
LOVASTATIN 63 43 62 44
RANITIDINE HCL 62 42 63 63
LOVAZA 62 48 63 157
FORTEO 62 62 63 346
BENAZEPRIL HCL 61 51 66 112
LIPITOR 60 57 67 47
LEVEMIR 58 58 68 195
AZOR 58 54 68 198
LANTUS 57 57 70 43
VYTORIN 57 57 70 145
CLOTRIMAZOLE-BETAMETHASONE 55 52 72 111
FLUTICASONE PROPIONATE 55 43 72 55
HYDROCODONE BIT-IBUPROFEN 54 54 S3 74 244
CEFUROXIME 53 48 75 170
OXYCODONE HCL 53 51 S2 75 54
AMITIZA 52 52 77 181
AMIODARONE HCL 52 52 77 168
NITROFURANTOIN MONO-MACRO 52 51 77 180
CARBIDOPA-LEVODOPA 52 52 77 80
FENOFIBRATE 51 50 81 109
ZETIA 51 51 81 51
DIVALPROEX SODIUM 51 51 81 53
LEVOFLOXACIN 50 43 84 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.